Phase 3 Trial Launched to Test Cabometyx-Tecentriq in Advanced Kidney Cancer

https://immuno-oncologynews.com/2020/07/27/exelixis-launches-phase-3-trial-testing-cabometyx-tecentriq-combo-in-advanced-kidney-cancer/
JOIN OUR MAILING LIST

 

 
 
 
 

IPIRA is committed to meeting the needs of people with disabilities in a timely manner by preventing and removing barriers to accessibility. We also adhere to the UC Berkeley policy on nondiscrimination, and protect the privacy of confidential information.